Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 1 1

Status

Unknown 3Completed 3

Sponsor Class

OTHER_GOV 4OTHER 2

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 9Breast 9Thoracic 6Plasma cell 3Genitourinary 3Tumor-Agnostic 1Lymphoid 1CNS 1

Conditions

Small Cell Lung Carcinoma 4Lung Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Carboplatin 551Pemetrexed 404Cisplatin 401Paclitaxel 273Docetaxel 255Gemcitabine 218pembrolizumab 191Bevacizumab 190Erlotinib Hydrochloride 184Radiotherapy 181Etoposide 147durvalumab 140Nivolumab 134Drug Therapy 127osimertinib 107atezolizumab 92Gefitinib 74Radiosurgery 72anlotinib 69Vinorelbine 68tislelizumab 52Irinotecan 51Ipilimumab 50130-nm albumin-bound paclitaxel 50Taxes 48Surgical Procedures, Operative 46Cetuximab 46sintilimab 45Albumin-Bound Paclitaxel 45apatinib 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Simvastatin × Thoracic × Clear all
NCT01156545 2022-04-06

BIBW 2992 Plus Simvastatin vs. BIBW 2992 in Previously Treated Patients With Advanced Non-adenocarcinomatous NSCLC

National Cancer Center, Korea

Phase 2 Completed
68 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT01441349 2022-04-06

Irinotecan/Cisplatin With or Without Simvastatin in Chemo-naive Patients With Extensive Disease-small Cell Lung Cancer

National Cancer Center, Korea

Phase 2 Unknown
192 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT04985201 2021-08-09

Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy

Shanghai Pulmonary Hospital, Shanghai, China

Phase 2 Unknown
40 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT04698941 2021-07-29

Combined Simvastatin and Albumin Paclitaxel in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy

Shanghai Pulmonary Hospital, Shanghai, China

Phase 2 Unknown
40 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT00452244 2017-08-25

Gefitinib With or Without Simvastatin in Non-Small Cell Lung Cancer (NSCLC)

National Cancer Center, Korea

Phase 2 Completed
110 enrolled
Thoracic

Lung Neoplasms

NCT00452634 2013-06-19

Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC)

National Cancer Center, Korea

Phase 2 Completed
62 enrolled
Thoracic

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡